Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion

被引:18
作者
Rijken, J. A. [1 ]
Niemeijer, N. D. [2 ]
Corssmit, E. P. M. [2 ]
Jonker, M. A. [3 ]
Leemans, C. R. [1 ]
Menko, F. H. [4 ,5 ]
Hensen, E. F. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1081 HZ Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, NL-1081 HZ Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 HZ Amsterdam, Netherlands
[5] Netherlands Canc Inst, Dept Clin Genet, Amsterdam, Netherlands
关键词
hereditary; paragangliomas; penetrance; pheochromocytomas; SDHB; GLOMUS TUMORS; INHERITANCE; MUTATIONS; HEAD; GENE;
D O I
10.1111/cge.12591
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In the Netherlands, the majority of hereditary paragangliomas (PGL) is caused by SDHD, SDHB and SDHAF2 mutations. Founder mutations in SDHD are particularly prevalent, but several SDHB founder mutations have also been described. Here, we describe an extended PGL family with a Dutch founder mutation in SDHB, c.201-4429_287-933del. The proband presented with apparently sporadic head and neck paraganglioma at advanced age. Subsequently, evaluation of the family identified several unaffected mutation carriers, asymptomatic and symptomatic PGL patients, and patients presenting with early-onset malignant pheochromocytoma. The calculated penetrance of the SDHB mutation in this kindred is lower than the risk suggested for SDHB mutations in the literature. This may represent a characteristic of this particular SDHB mutation, but may also be a reflection of the inclusion of relatively large numbers of asymptomatic mutation carriers in this family and adequate statistical correction for ascertainment bias. The low penetrance of SDHB mutations may obscure the hereditary nature of SDHB-linked disease and is important in the counseling of SDHB-linked patients. Risk estimates should preferably be based on the specific mutation involved.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 16 条
[11]   Tumor Risks and Genotype-Phenotype-Proteotype Analysis in 358 Patients With Germline Mutations in SDHB and SDHD [J].
Ricketts, Christopher J. ;
Forman, Julia R. ;
Rattenberry, Eleanor ;
Bradshaw, Nicola ;
Lalloo, Fiona ;
Izatt, Louise ;
Cole, Trevor R. ;
Armstrong, Ruth ;
Kumar, V. K. Ajith ;
Morrison, Patrick J. ;
Atkinson, A. Brew ;
Douglas, Fiona ;
Ball, Steve G. ;
Cook, Jackie ;
Srirangalingam, Umasuthan ;
Killick, Pip ;
Kirby, Gail ;
Aylwin, Simon ;
Woodward, Emma R. ;
Evans, D. Gareth R. ;
Hodgson, Shirley V. ;
Murday, Vicky ;
Chew, Shern L. ;
Connell, John M. ;
Blunde, Tom L. ;
MacDonald, Fiona ;
Maher, Eamonn R. .
HUMAN MUTATION, 2010, 31 (01) :41-51
[12]   Are We Overestimating the Penetrance of Mutations in SDHB? [J].
Schiavi, Francesca ;
Milne, Roger L. ;
Anda, Emma ;
Blay, Pilar ;
Castellano, Maurizio ;
Opocher, Giuseppe ;
Robledo, Mercedes ;
Cascon, Alberto .
HUMAN MUTATION, 2010, 31 (06) :761-762
[13]   Penetrance and clinical consequences of a gross SDHB deletion in a large family [J].
Solis, D. C. ;
Burnichon, N. ;
Timmers, H. J. L. M. ;
Raygada, M. J. ;
Kozupa, A. ;
Merino, M. J. ;
Makey, D. ;
Adams, K. T. ;
Venisse, A. ;
Gimenez-Roqueplo, A-P ;
Pacak, K. .
CLINICAL GENETICS, 2009, 75 (04) :354-363
[14]   Glomus tumours and genomic imprinting: Influence of inheritance along the paternal or maternal line [J].
Struycken, PM ;
Cremers, CWRJ ;
Mariman, ECM ;
Joosten, FBM ;
Bleker, RJTM .
CLINICAL OTOLARYNGOLOGY, 1997, 22 (01) :71-76
[15]   Phenotype of SDHB mutation carriers in the Netherlands [J].
van Hulsteijn, Leonie T. ;
Niemeijer, Nienke D. ;
Hes, Frederik J. ;
Bayley, Jean-Pierre ;
Tops, Carli M. ;
Jansen, Jeroen C. ;
Corssmit, Eleonora P. M. .
FAMILIAL CANCER, 2014, 13 (04) :651-657
[16]  
VANDERMEY AGL, 1989, LANCET, V2, P1291